Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study
- Author
- UCKUN, F. M; GAYNON, P; SATHER, H; ARTHUR, D; TRIGG, M; TUBERGEN, D; NACHMAN, J; STEINHERZ, P; SENSEL, M. G; REAMAN, G. R
Biotherapy Institute, University of Minnesota, Roseville, United States
Children's Cancer Group ALL Biology Reference Lab, University of Minnesota, Roseville, United States
Department of Hematology-Oncology Children National Medical Center, Washington, DC, United States
Department of Pediatric Hematology-Oncology, University of Iowa Hospital and Clinics, Iowa City, United States
Department of Pediatric Hematology-Oncology, University of Wisconsin, Madison, United States
Department of Pediatrics Memorial Sloan-Kettering Cancer Center, New York, NY, United States
Department of Pediatrics, M.D. Anderson Cancer Center, Houston, TX, United States
Department of Preventive Medicine, Uniersity of Southern California, Los Angeles, United States
Group Operations Center, Children Cancer Group, Arcadia, CA, United States
Section of Pediatric Hematology-Oncology, University of Chicago Medical Center, Chicago, IL, United States
University of Minnesota Medical Center, Minneapolis, MN, United States
usGroup Operations Center, Children Cancer Group, Arcadia, CA, United States - Source
Blood. 1997, Vol 89, Num 7, pp 2488-2493 ; ref : 23 ref
- ISSN
- 0006-4971
- Scientific domain
- Medical oncology; Hematology
- Publisher
- The Americain Society of Hematology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Aigu Anticancéreux Chimiothérapie Enfant Etude statistique Leucémie lymphoblastique Phénotype Pronostic Symptomatologie Traitement Antigène CD19 Antigène CD2 Biphénotype Homme Hémopathie maligne Lymphoprolifératif syndrome
- Keyword (en)
- Acute Antineoplastic agent Chemotherapy Child Statistical study Acute lymphocytic leukemia Phenotype Prognosis Symptomatology Treatment Human Malignant hemopathy Lymphoproliferative syndrome
- Keyword (es)
- Agudo Anticanceroso Quimioterapia Niño Estudio estadístico Leucemia linfoblástica Fenotipo Pronóstico Sintomatología Tratamiento Hombre Hemopatía maligna Linfoproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2635687
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:141:\"Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"89\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2488\";s:8:\"\u0000*\u0000epage\";s:4:\"2493\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"UCKUN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"F. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"GAYNON, P\";i:1;s:9:\"SATHER, H\";i:2;s:9:\"ARTHUR, D\";i:3;s:8:\"TRIGG, M\";i:4;s:11:\"TUBERGEN, D\";i:5;s:10:\"NACHMAN, J\";i:6;s:12:\"STEINHERZ, P\";i:7;s:12:\"SENSEL, M. G\";i:8;s:12:\"REAMAN, G. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:141:\"Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:141:\"Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"89\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2488\";s:8:\"\u0000*\u0000epage\";s:4:\"2493\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"UCKUN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"F. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"GAYNON, P\";i:1;s:9:\"SATHER, H\";i:2;s:9:\"ARTHUR, D\";i:3;s:8:\"TRIGG, M\";i:4;s:11:\"TUBERGEN, D\";i:5;s:10:\"NACHMAN, J\";i:6;s:12:\"STEINHERZ, P\";i:7;s:12:\"SENSEL, M. G\";i:8;s:12:\"REAMAN, G. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:141:\"Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:141:\"Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"89\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2488\";s:8:\"\u0000*\u0000epage\";s:4:\"2493\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"UCKUN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"F. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"GAYNON, P\";i:1;s:9:\"SATHER, H\";i:2;s:9:\"ARTHUR, D\";i:3;s:8:\"TRIGG, M\";i:4;s:11:\"TUBERGEN, D\";i:5;s:10:\"NACHMAN, J\";i:6;s:12:\"STEINHERZ, P\";i:7;s:12:\"SENSEL, M. G\";i:8;s:12:\"REAMAN, G. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:141:\"Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:141:\"Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"89\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2488\";s:8:\"\u0000*\u0000epage\";s:4:\"2493\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"UCKUN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"F. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"GAYNON, P\";i:1;s:9:\"SATHER, H\";i:2;s:9:\"ARTHUR, D\";i:3;s:8:\"TRIGG, M\";i:4;s:11:\"TUBERGEN, D\";i:5;s:10:\"NACHMAN, J\";i:6;s:12:\"STEINHERZ, P\";i:7;s:12:\"SENSEL, M. G\";i:8;s:12:\"REAMAN, G. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:141:\"Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:141:\"Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"89\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2488\";s:8:\"\u0000*\u0000epage\";s:4:\"2493\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"UCKUN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"F. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"GAYNON, P\";i:1;s:9:\"SATHER, H\";i:2;s:9:\"ARTHUR, D\";i:3;s:8:\"TRIGG, M\";i:4;s:11:\"TUBERGEN, D\";i:5;s:10:\"NACHMAN, J\";i:6;s:12:\"STEINHERZ, P\";i:7;s:12:\"SENSEL, M. G\";i:8;s:12:\"REAMAN, G. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:141:\"Clinical features and treatment outcome of children with biphenotypic CD2+CD19+ acute lymphoblastic leukemia: A children's cancer group study\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
